Literature DB >> 24487398

Mini-Mental Parkinson: first validation study of a new bedside test constructed for Parkinson's disease.

F Mahieux1, D Michelet2, M J Manifacier2, F Boller3, J Fermanian4, A Guillard2.   

Abstract

We have developed a brief screening test aimed at identifying cognitive disorders in Parkinson's disease. The Mini-Mental Parkinson derives from the Mini-Mental State Examination of Folstein. It includes seven ordered subsections, with a total score of 32. A pilot study was conducted in 50 community-dwelling parkinsonian patients, in order to establish its metrological qualities. Comparisons were made with a neuropsychological battery including several tests widely used in the assessment of specific cognitive disorders in Parkinson's disease. The correlations between the Mini-Mental Parkinson and each component of this battery were substantial, especially for the performance subtests of the WAIS-R (r = 0.62 to 0.72), the Stroop test (r = 0.65) the 15-objects test (r = 0.64), the word fluency (r = 0.63) and the Odd Man Out test (r = 0.61). The validity of each subtest of the Mini-Mental Parkinson was adequate except for one, based on a word choice, which requires a modification in French before definitive use. The test-retest reliability was high (r = 0.84). There was a significant difference in the mean scores in cases with confusional event (22.4), even without current signs of dementia, compared with patients with no such history (27.2). In conclusion, this brief test is suitable for assessment of parkinsonian patients.

Entities:  

Keywords:  Cognitive disorders; Dementia; Neuropsychological assessment; Parkinson's disease; screening test

Year:  1995        PMID: 24487398     DOI: 10.3233/BEN-1995-8102

Source DB:  PubMed          Journal:  Behav Neurol        ISSN: 0953-4180            Impact factor:   3.342


  19 in total

1.  A recommended scale for cognitive screening in clinical trials of Parkinson's disease.

Authors:  Kelvin L Chou; Melissa M Amick; Jason Brandt; Richard Camicioli; Karen Frei; Darren Gitelman; Jennifer Goldman; John Growdon; Howard I Hurtig; Bonnie Levin; Irene Litvan; Laura Marsh; Tanya Simuni; Alexander I Tröster; Ergun Y Uc
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Psychometric properties of the Italian version of the Scales for Outcomes in Parkinson's disease- Cognition (SCOPA-Cog).

Authors:  V Isella; C Mapelli; N Morielli; D De Gaspari; C Siri; G Pezzoli; A Antonini; M Poletti; U Bonuccelli; L Picchi; A Napolitano; M Vista; M Veglia; F Piamarta; F Grassi; I M Appollonio
Journal:  Funct Neurol       Date:  2013 Apr-May

3.  The impact of motor and non motor symptoms on health state values in newly diagnosed idiopathic Parkinson's disease.

Authors:  James Shearer; Colin Green; Carl E Counsell; John P Zajicek
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

4.  Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.

Authors:  Silvia Picazio; Viviana Ponzo; Carlo Caltagirone; Livia Brusa; Giacomo Koch
Journal:  J Neurol       Date:  2018-07-06       Impact factor: 4.849

5.  Feeling of presence in Parkinson's disease.

Authors:  Gilles Fénelon; Thierry Soulas; Laurent Cleret de Langavant; Iris Trinkler; Anne-Catherine Bachoud-Lévi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-05-07       Impact factor: 10.154

Review 6.  The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential.

Authors:  K Ray Chaudhuri; L Yates; P Martinez-Martin
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

7.  Validity and metric of MiniMental Parkinson and MiniMental State Examination in Parkinson's disease.

Authors:  V Isella; C Mapelli; N Morielli; D De Gaspari; C Siri; G Pezzoli; A Antonini; M Poletti; U Bonuccelli; L Picchi; A Napolitano; M Vista; A Greco; I M Appollonio
Journal:  Neurol Sci       Date:  2013-02-20       Impact factor: 3.307

8.  Mini mental Parkinson test: standardization and normative data on an Italian sample.

Authors:  Alberto Costa; Eriola Bagoj; Marco Monaco; Silvia Zabberoni; Salvatore De Rosa; Ciro Mundi; Carlo Caltagirone; Giovanni Augusto Carlesimo
Journal:  Neurol Sci       Date:  2013-03-12       Impact factor: 3.307

9.  Effect of levodopa on frontal-subcortical and posterior cortical functioning in patients with Parkinson's disease.

Authors:  Amara Gul; Javed Yousaf
Journal:  Singapore Med J       Date:  2018-09-24       Impact factor: 1.858

Review 10.  Quality of life in Parkinson's disease.

Authors:  J A Opara; W Brola; M Leonardi; B Błaszczyk
Journal:  J Med Life       Date:  2012-12-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.